This report aims to provide a comprehensive presentation of the global market for Drugs for Hormonal Replacement Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Hormonal Replacement Therapy. This report contains market size and forecasts of Drugs for Hormonal Replacement Therapy in global, including the following market information:
Global Drugs for Hormonal Replacement Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Drugs for Hormonal Replacement Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Estrogen Replacement Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Drugs for Hormonal Replacement Therapy include Novartis AG, Bayer AG, Pfizer Inc., Novo Nordisk A/S, Eli Lilly and Company, Abbott, Mylan Laboratories, Merck & Co. and Hisamitsu Pharmaceutical Co. Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Drugs for Hormonal Replacement Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Hormonal Replacement Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Drugs for Hormonal Replacement Therapy Market Segment Percentages, by Type, 2022 (%)
Estrogen Replacement Therapy
Human Growth Hormone Replacement Therapy
Thyroid Replacement Therapy
Testosterone Replacement Therapy
Global Drugs for Hormonal Replacement Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Drugs for Hormonal Replacement Therapy Market Segment Percentages, by Application, 2022 (%)
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
Menopause
Others
Global Drugs for Hormonal Replacement Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Drugs for Hormonal Replacement Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs for Hormonal Replacement Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Drugs for Hormonal Replacement Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Bayer AG
Pfizer Inc.
Novo Nordisk A/S
Eli Lilly and Company
Abbott
Mylan Laboratories
Merck & Co.
Hisamitsu Pharmaceutical Co. Inc.
Teva Pharmaceutical Industries Ltd.
F.Hoffmann-La Roche
Noven Pharmaceuticals Inc.
Orion Pharma AB
Allergan Plc.
QuatRx Pharmaceuticals
Wyeth
Amgen Inc.
Roche
Genentech
TherapeuticsMD
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drugs for Hormonal Replacement Therapy, market overview.
Chapter 2: Global Drugs for Hormonal Replacement Therapy market size in revenue.
Chapter 3: Detailed analysis of Drugs for Hormonal Replacement Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drugs for Hormonal Replacement Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Drugs for Hormonal Replacement Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Hormonal Replacement Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Hormonal Replacement Therapy Overall Market Size
2.1 Global Drugs for Hormonal Replacement Therapy Market Size: 2022 VS 2029
2.2 Global Drugs for Hormonal Replacement Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs for Hormonal Replacement Therapy Players in Global Market
3.2 Top Global Drugs for Hormonal Replacement Therapy Companies Ranked by Revenue
3.3 Global Drugs for Hormonal Replacement Therapy Revenue by Companies
3.4 Top 3 and Top 5 Drugs for Hormonal Replacement Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Drugs for Hormonal Replacement Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs for Hormonal Replacement Therapy Players in Global Market
3.6.1 List of Global Tier 1 Drugs for Hormonal Replacement Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Drugs for Hormonal Replacement Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Drugs for Hormonal Replacement Therapy Market Size Markets, 2022 & 2029
4.1.2 Estrogen Replacement Therapy
4.1.3 Human Growth Hormone Replacement Therapy
4.1.4 Thyroid Replacement Therapy
4.1.5 Testosterone Replacement Therapy
4.2 By Type - Global Drugs for Hormonal Replacement Therapy Revenue & Forecasts
4.2.1 By Type - Global Drugs for Hormonal Replacement Therapy Revenue, 2018-2023
4.2.2 By Type - Global Drugs for Hormonal Replacement Therapy Revenue, 2024-2029
4.2.3 By Type - Global Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs for Hormonal Replacement Therapy Market Size, 2022 & 2029
5.1.2 Hypothyroidism
5.1.3 Male Hypogonadism
5.1.4 Growth Hormone Deficiency
5.1.5 Menopause
5.1.6 Others
5.2 By Application - Global Drugs for Hormonal Replacement Therapy Revenue & Forecasts
5.2.1 By Application - Global Drugs for Hormonal Replacement Therapy Revenue, 2018-2023
5.2.2 By Application - Global Drugs for Hormonal Replacement Therapy Revenue, 2024-2029
5.2.3 By Application - Global Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Drugs for Hormonal Replacement Therapy Market Size, 2022 & 2029
6.2 By Region - Global Drugs for Hormonal Replacement Therapy Revenue & Forecasts
6.2.1 By Region - Global Drugs for Hormonal Replacement Therapy Revenue, 2018-2023
6.2.2 By Region - Global Drugs for Hormonal Replacement Therapy Revenue, 2024-2029
6.2.3 By Region - Global Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Drugs for Hormonal Replacement Therapy Revenue, 2018-2029
6.3.2 US Drugs for Hormonal Replacement Therapy Market Size, 2018-2029
6.3.3 Canada Drugs for Hormonal Replacement Therapy Market Size, 2018-2029
6.3.4 Mexico Drugs for Hormonal Replacement Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Drugs for Hormonal Replacement Therapy Revenue, 2018-2029
6.4.2 Germany Drugs for Hormonal Replacement Therapy Market Size, 2018-2029
6.4.3 France Drugs for Hormonal Replacement Therapy Market Size, 2018-2029
6.4.4 U.K. Drugs for Hormonal Replacement Therapy Market Size, 2018-2029
6.4.5 Italy Drugs for Hormonal Replacement Therapy Market Size, 2018-2029
6.4.6 Russia Drugs for Hormonal Replacement Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Drugs for Hormonal Replacement Therapy Market Size, 2018-2029
6.4.8 Benelux Drugs for Hormonal Replacement Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Drugs for Hormonal Replacement Therapy Revenue, 2018-2029
6.5.2 China Drugs for Hormonal Replacement Therapy Market Size, 2018-2029
6.5.3 Japan Drugs for Hormonal Replacement Therapy Market Size, 2018-2029
6.5.4 South Korea Drugs for Hormonal Replacement Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Drugs for Hormonal Replacement Therapy Market Size, 2018-2029
6.5.6 India Drugs for Hormonal Replacement Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Drugs for Hormonal Replacement Therapy Revenue, 2018-2029
6.6.2 Brazil Drugs for Hormonal Replacement Therapy Market Size, 2018-2029
6.6.3 Argentina Drugs for Hormonal Replacement Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drugs for Hormonal Replacement Therapy Revenue, 2018-2029
6.7.2 Turkey Drugs for Hormonal Replacement Therapy Market Size, 2018-2029
6.7.3 Israel Drugs for Hormonal Replacement Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Drugs for Hormonal Replacement Therapy Market Size, 2018-2029
6.7.5 UAE Drugs for Hormonal Replacement Therapy Market Size, 2018-2029
7 Drugs for Hormonal Replacement Therapy Companies Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Drugs for Hormonal Replacement Therapy Major Product Offerings
7.1.4 Novartis AG Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Bayer AG
7.2.1 Bayer AG Company Summary
7.2.2 Bayer AG Business Overview
7.2.3 Bayer AG Drugs for Hormonal Replacement Therapy Major Product Offerings
7.2.4 Bayer AG Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.2.5 Bayer AG Key News & Latest Developments
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Company Summary
7.3.2 Pfizer Inc. Business Overview
7.3.3 Pfizer Inc. Drugs for Hormonal Replacement Therapy Major Product Offerings
7.3.4 Pfizer Inc. Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.3.5 Pfizer Inc. Key News & Latest Developments
7.4 Novo Nordisk A/S
7.4.1 Novo Nordisk A/S Company Summary
7.4.2 Novo Nordisk A/S Business Overview
7.4.3 Novo Nordisk A/S Drugs for Hormonal Replacement Therapy Major Product Offerings
7.4.4 Novo Nordisk A/S Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.4.5 Novo Nordisk A/S Key News & Latest Developments
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Company Summary
7.5.2 Eli Lilly and Company Business Overview
7.5.3 Eli Lilly and Company Drugs for Hormonal Replacement Therapy Major Product Offerings
7.5.4 Eli Lilly and Company Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.5.5 Eli Lilly and Company Key News & Latest Developments
7.6 Abbott
7.6.1 Abbott Company Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Drugs for Hormonal Replacement Therapy Major Product Offerings
7.6.4 Abbott Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.6.5 Abbott Key News & Latest Developments
7.7 Mylan Laboratories
7.7.1 Mylan Laboratories Company Summary
7.7.2 Mylan Laboratories Business Overview
7.7.3 Mylan Laboratories Drugs for Hormonal Replacement Therapy Major Product Offerings
7.7.4 Mylan Laboratories Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.7.5 Mylan Laboratories Key News & Latest Developments
7.8 Merck & Co.
7.8.1 Merck & Co. Company Summary
7.8.2 Merck & Co. Business Overview
7.8.3 Merck & Co. Drugs for Hormonal Replacement Therapy Major Product Offerings
7.8.4 Merck & Co. Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.8.5 Merck & Co. Key News & Latest Developments
7.9 Hisamitsu Pharmaceutical Co. Inc.
7.9.1 Hisamitsu Pharmaceutical Co. Inc. Company Summary
7.9.2 Hisamitsu Pharmaceutical Co. Inc. Business Overview
7.9.3 Hisamitsu Pharmaceutical Co. Inc. Drugs for Hormonal Replacement Therapy Major Product Offerings
7.9.4 Hisamitsu Pharmaceutical Co. Inc. Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.9.5 Hisamitsu Pharmaceutical Co. Inc. Key News & Latest Developments
7.10 Teva Pharmaceutical Industries Ltd.
7.10.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.10.3 Teva Pharmaceutical Industries Ltd. Drugs for Hormonal Replacement Therapy Major Product Offerings
7.10.4 Teva Pharmaceutical Industries Ltd. Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.10.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.11 F.Hoffmann-La Roche
7.11.1 F.Hoffmann-La Roche Company Summary
7.11.2 F.Hoffmann-La Roche Business Overview
7.11.3 F.Hoffmann-La Roche Drugs for Hormonal Replacement Therapy Major Product Offerings
7.11.4 F.Hoffmann-La Roche Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.11.5 F.Hoffmann-La Roche Key News & Latest Developments
7.12 Noven Pharmaceuticals Inc.
7.12.1 Noven Pharmaceuticals Inc. Company Summary
7.12.2 Noven Pharmaceuticals Inc. Business Overview
7.12.3 Noven Pharmaceuticals Inc. Drugs for Hormonal Replacement Therapy Major Product Offerings
7.12.4 Noven Pharmaceuticals Inc. Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.12.5 Noven Pharmaceuticals Inc. Key News & Latest Developments
7.13 Orion Pharma AB
7.13.1 Orion Pharma AB Company Summary
7.13.2 Orion Pharma AB Business Overview
7.13.3 Orion Pharma AB Drugs for Hormonal Replacement Therapy Major Product Offerings
7.13.4 Orion Pharma AB Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.13.5 Orion Pharma AB Key News & Latest Developments
7.14 Allergan Plc.
7.14.1 Allergan Plc. Company Summary
7.14.2 Allergan Plc. Business Overview
7.14.3 Allergan Plc. Drugs for Hormonal Replacement Therapy Major Product Offerings
7.14.4 Allergan Plc. Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.14.5 Allergan Plc. Key News & Latest Developments
7.15 QuatRx Pharmaceuticals
7.15.1 QuatRx Pharmaceuticals Company Summary
7.15.2 QuatRx Pharmaceuticals Business Overview
7.15.3 QuatRx Pharmaceuticals Drugs for Hormonal Replacement Therapy Major Product Offerings
7.15.4 QuatRx Pharmaceuticals Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.15.5 QuatRx Pharmaceuticals Key News & Latest Developments
7.16 Wyeth
7.16.1 Wyeth Company Summary
7.16.2 Wyeth Business Overview
7.16.3 Wyeth Drugs for Hormonal Replacement Therapy Major Product Offerings
7.16.4 Wyeth Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.16.5 Wyeth Key News & Latest Developments
7.17 Amgen Inc.
7.17.1 Amgen Inc. Company Summary
7.17.2 Amgen Inc. Business Overview
7.17.3 Amgen Inc. Drugs for Hormonal Replacement Therapy Major Product Offerings
7.17.4 Amgen Inc. Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.17.5 Amgen Inc. Key News & Latest Developments
7.18 Roche
7.18.1 Roche Company Summary
7.18.2 Roche Business Overview
7.18.3 Roche Drugs for Hormonal Replacement Therapy Major Product Offerings
7.18.4 Roche Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.18.5 Roche Key News & Latest Developments
7.19 Genentech
7.19.1 Genentech Company Summary
7.19.2 Genentech Business Overview
7.19.3 Genentech Drugs for Hormonal Replacement Therapy Major Product Offerings
7.19.4 Genentech Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.19.5 Genentech Key News & Latest Developments
7.20 TherapeuticsMD
7.20.1 TherapeuticsMD Company Summary
7.20.2 TherapeuticsMD Business Overview
7.20.3 TherapeuticsMD Drugs for Hormonal Replacement Therapy Major Product Offerings
7.20.4 TherapeuticsMD Drugs for Hormonal Replacement Therapy Revenue in Global Market (2018-2023)
7.20.5 TherapeuticsMD Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Drugs for Hormonal Replacement Therapy Market Opportunities & Trends in Global Market
Table 2. Drugs for Hormonal Replacement Therapy Market Drivers in Global Market
Table 3. Drugs for Hormonal Replacement Therapy Market Restraints in Global Market
Table 4. Key Players of Drugs for Hormonal Replacement Therapy in Global Market
Table 5. Top Drugs for Hormonal Replacement Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Drugs for Hormonal Replacement Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Drugs for Hormonal Replacement Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Drugs for Hormonal Replacement Therapy Product Type
Table 9. List of Global Tier 1 Drugs for Hormonal Replacement Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Hormonal Replacement Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Drugs for Hormonal Replacement Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Drugs for Hormonal Replacement Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Drugs for Hormonal Replacement Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Drugs for Hormonal Replacement Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Drugs for Hormonal Replacement Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Novartis AG Company Summary
Table 31. Novartis AG Drugs for Hormonal Replacement Therapy Product Offerings
Table 32. Novartis AG Drugs for Hormonal Replacement Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis AG Key News & Latest Developments
Table 34. Bayer AG Company Summary
Table 35. Bayer AG Drugs for Hormonal Replacement Therapy Product Offerings
Table 36. Bayer AG Drugs for Hormonal Replacement Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Bayer AG Key News & Latest Developments
Table 38. Pfizer Inc. Company Summary
Table 39. Pfizer Inc. Drugs for Hormonal Replacement Therapy Product Offerings
Table 40. Pfizer Inc. Drugs for Hormonal Replacement Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Pfizer Inc. Key News & Latest Developments
Table 42. Novo Nordisk A/S Company Summary
Table 43. Novo Nordisk A/S Drugs for Hormonal Replacement Therapy Product Offerings
Table 44. Novo Nordisk A/S Drugs for Hormonal Replacement Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Novo Nordisk A/S Key News & Latest Developments
Table 46. Eli Lilly and Company Company Summary
Table 47. Eli Lilly and Company Drugs for Hormonal Replacement Therapy Product Offerings
Table 48. Eli Lilly and Company Drugs for Hormonal Replacement Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Eli Lilly and Company Key News & Latest Developments
Table 50. Abbott Company Summary
Table 51. Abbott Drugs for Hormonal Replacement Therapy Product Offerings
Table 52. Abbott Drugs for Hormonal Replacement Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Abbott Key News & Latest Developments
Table 54. Mylan Laboratories Company Summary
Table 55. Mylan Laboratories Drugs for Hormonal Replacement Therapy Product Offerings
Table 56. Mylan Laboratories Drugs for Hormonal Replacement Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Mylan Laboratories Key News & Latest Developments
Table 58. Merck & Co. Company Summary
Table 59. Merck & Co. Drugs for Hormonal Replacement Therapy Product Offerings
Table 60. Merck & Co. Drugs for Hormonal Replacement Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Merck & Co. Key News & Latest Developments
Table 62. Hisamitsu Pharmaceutical Co. Inc. Company Summary
Table 63. Hisamitsu Pharmaceutical Co. Inc. Drugs for Hormonal Replacement Therapy Product Offerings
Table 64. Hisamitsu Pharmaceutical Co. Inc. Drugs for Hormonal Replacement Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Hisamitsu Pharmaceutical Co. Inc. Key News & Latest Developments
Table 66. Teva Pharmaceutical Industries Ltd. Company Summary
Table 67. Teva Pharmaceutical Industries Ltd. Drugs for Hormonal Replacement Therapy Product Offerings
Table 68. Teva Pharmaceutical Industries Ltd. Drugs for Hormonal Replacement Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 70. F.Hoffmann-La Roche Company Summary
Table 71. F.Hoffmann-La Roche Drugs for Hormonal Replacement Therapy Product Offerings
Table 72. F.Hoffmann-La Roche Drugs for Hormonal Replacement Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. F.Hoffmann-La Roche Key News & Latest Developments
Table 74. Noven Pharmaceuticals Inc. Company Summary
Table 75. Noven Pharmaceuticals Inc. Drugs for Hormonal Replacement Therapy Product Offerings
Table 76. Noven Pharmaceuticals Inc. Drugs for Hormonal Replacement Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Noven Pharmaceuticals Inc. Key News & Latest Developments
Table 78. Orion Pharma AB Company Summary
Table 79. Orion Pharma AB Drugs for Hormonal Replacement Therapy Product Offerings
Table 80. Orion Pharma AB Drugs for Hormonal Replacement Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Orion Pharma AB Key News & Latest Developments
Table 82. Allergan Plc. Company Summary
Table 83. Allergan Plc. Drugs for Hormonal Replacement Therapy Product Offerings
Table 84. Allergan Plc. Drugs for Hormonal Replacement Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. Allergan Plc. Key News & Latest Developments
Table 86. QuatRx Pharmaceuticals Company Summary
Table 87. QuatRx Pharmaceuticals Drugs for Hormonal Replacement Therapy Product Offerings
Table 88. QuatRx Pharmaceuticals Drugs for Hormonal Replacement Therapy Revenue (US$, Mn) & (2018-2023)
Table 89. QuatRx Pharmaceuticals Key News & Latest Developments
Table 90. Wyeth Company Summary
Table 91. Wyeth Drugs for Hormonal Replacement Therapy Product Offerings
Table 92. Wyeth Drugs for Hormonal Replacement Therapy Revenue (US$, Mn) & (2018-2023)
Table 93. Wyeth Key News & Latest Developments
Table 94. Amgen Inc. Company Summary
Table 95. Amgen Inc. Drugs for Hormonal Replacement Therapy Product Offerings
Table 96. Amgen Inc. Drugs for Hormonal Replacement Therapy Revenue (US$, Mn) & (2018-2023)
Table 97. Amgen Inc. Key News & Latest Developments
Table 98. Roche Company Summary
Table 99. Roche Drugs for Hormonal Replacement Therapy Product Offerings
Table 100. Roche Drugs for Hormonal Replacement Therapy Revenue (US$, Mn) & (2018-2023)
Table 101. Roche Key News & Latest Developments
Table 102. Genentech Company Summary
Table 103. Genentech Drugs for Hormonal Replacement Therapy Product Offerings
Table 104. Genentech Drugs for Hormonal Replacement Therapy Revenue (US$, Mn) & (2018-2023)
Table 105. Genentech Key News & Latest Developments
Table 106. TherapeuticsMD Company Summary
Table 107. TherapeuticsMD Drugs for Hormonal Replacement Therapy Product Offerings
Table 108. TherapeuticsMD Drugs for Hormonal Replacement Therapy Revenue (US$, Mn) & (2018-2023)
Table 109. TherapeuticsMD Key News & Latest Developments
List of Figures
Figure 1. Drugs for Hormonal Replacement Therapy Segment by Type in 2022
Figure 2. Drugs for Hormonal Replacement Therapy Segment by Application in 2022
Figure 3. Global Drugs for Hormonal Replacement Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Drugs for Hormonal Replacement Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Drugs for Hormonal Replacement Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drugs for Hormonal Replacement Therapy Revenue in 2022
Figure 8. By Type - Global Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2029
Figure 16. US Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2029
Figure 28. China Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Drugs for Hormonal Replacement Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Drugs for Hormonal Replacement Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Novartis AG Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bayer AG Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Pfizer Inc. Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novo Nordisk A/S Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Eli Lilly and Company Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Abbott Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Mylan Laboratories Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Merck & Co. Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Hisamitsu Pharmaceutical Co. Inc. Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Teva Pharmaceutical Industries Ltd. Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. F.Hoffmann-La Roche Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Noven Pharmaceuticals Inc. Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Orion Pharma AB Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Allergan Plc. Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. QuatRx Pharmaceuticals Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Wyeth Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Amgen Inc. Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Roche Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Genentech Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. TherapeuticsMD Drugs for Hormonal Replacement Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
